<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01003483</url>
  </required_header>
  <id_info>
    <org_study_id>616</org_study_id>
    <nct_id>NCT01003483</nct_id>
  </id_info>
  <brief_title>Metformin Versus Orlistat in Obese Polycystic Ovary Syndrome (PCOS) Patients</brief_title>
  <official_title>Orlistat Administration Facilitates the Obesity Treatment Among Obese PCOS Women</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Yazd Research &amp; Clinical Center for Infertility</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Yazd Medical University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Yazd Research &amp; Clinical Center for Infertility</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to compare the influence of Orlistat and Metformin on obesity
      treatment in obese PCOS women.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In a randomized clinical trial study, 80 obese women with BMIâ‰¥30, oligomenorrhae, hirsutism
      and presence of &gt; 12 ovarian follicles (2-10mm diameter), were evaluated. In metformin group
      , metformin was administered for patients 1500 mg daily for three months. In orlistate group,
      patients used orlistat tablets (120 mg, 3 times a day) for three months. BMI, serum LH and
      FSH levels, serum triglyceride and cholesterol levels and also patients' ovulation was
      compared before and after treatment.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>November 2008</start_date>
  <completion_date type="Actual">October 2009</completion_date>
  <primary_completion_date type="Actual">August 2009</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Body Mass Index (BMI)</measure>
    <time_frame>3 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Ovulatory</measure>
    <time_frame>3 months</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">80</enrollment>
  <condition>Obesity</condition>
  <arm_group>
    <arm_group_label>orlistat</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>orlistat</intervention_name>
    <description>Tablet,120mg,three times a day,three months</description>
    <arm_group_label>orlistat</arm_group_label>
    <other_name>Xenical</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  BMI&gt;= 30

          -  PCOS

        Exclusion Criteria:

          -  Drug use during last three months
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>15 Years</minimum_age>
    <maximum_age>39 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Abbas Aflatoonian, Professor</last_name>
    <role>Principal Investigator</role>
    <affiliation>Research and Clinical center for Infertility</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Research and Clinical Center for Infertility</name>
      <address>
        <city>Yazd</city>
        <zip>8916877391</zip>
        <country>Iran, Islamic Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Iran, Islamic Republic of</country>
  </location_countries>
  <verification_date>October 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 27, 2009</study_first_submitted>
  <study_first_submitted_qc>October 27, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 28, 2009</study_first_posted>
  <last_update_submitted>October 27, 2009</last_update_submitted>
  <last_update_submitted_qc>October 27, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 28, 2009</last_update_posted>
  <responsible_party>
    <name_title>Department of Obstetrics and Gynecology</name_title>
    <organization>Yazd Research &amp; Clinical Center for Infertility</organization>
  </responsible_party>
  <keyword>metformin</keyword>
  <keyword>orlistat</keyword>
  <keyword>pcos</keyword>
  <keyword>obese</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Obesity</mesh_term>
    <mesh_term>Polycystic Ovary Syndrome</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Metformin</mesh_term>
    <mesh_term>Orlistat</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

